Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours
A gene editing milestone: Will the FDA approve CASGEVY, the first CRISPR-based therapy approved in the U.K.?
Still a relatively new technology, CRISPR has been heralded in recent years as having the potential to tackle a range of diseases. And now, it has finally proved its worth. In a world first, the U.K....
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours
The biggest private biotech investments in November 2023
The companies Cambrian Innovation, Terremoto Biosciences, and VectorY Therapeutics bagged the biggest biotech investments in November 2023. Around the world, oncology and central nervous system...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours
BIO-Europe 2023: top ten highlights
The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Ten gift ideas for a biotech enthusiast this holiday season
Socks and sweaters are great gifts for the winter, but sometimes, a bit of biotech love goes a long way. Here’s a list of biotechnology-themed holiday gifts to get for your friends and family. From...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 5 jours
FDA CAR-T cell therapy warning: Are T cells malignant?
Chimeric antigen receptor (CAR) T cell therapies have emerged as groundbreaking treatments for various hematologic cancers, demonstrating remarkable efficacy in targeting specific cancer cells....
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne